Années de vie ajustées sur la qualité : Questions médicales fréquentes
Nom anglais: Quality-Adjusted Life Years
Descriptor UI:D019057
Tree Number:N06.850.520.308.985.450.875
Termes MeSH sélectionnés :
Immunization Programs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Années de vie ajustées sur la qualité : Questions médicales les plus fréquentes",
"headline": "Années de vie ajustées sur la qualité : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Années de vie ajustées sur la qualité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-21",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Années de vie ajustées sur la qualité"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Espérance de vie",
"url": "https://questionsmedicales.fr/mesh/D008017",
"about": {
"@type": "MedicalCondition",
"name": "Espérance de vie",
"code": {
"@type": "MedicalCode",
"code": "D008017",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.308.985.450"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Années de vie ajustées sur la qualité",
"alternateName": "Quality-Adjusted Life Years",
"code": {
"@type": "MedicalCode",
"code": "D019057",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Werner B F Brouwer",
"url": "https://questionsmedicales.fr/author/Werner%20B%20F%20Brouwer",
"affiliation": {
"@type": "Organization",
"name": "Erasmus School of Health Policy & Management (ESHPM), Erasmus University, Rotterdam, the Netherlands."
}
},
{
"@type": "Person",
"name": "Lei Si",
"url": "https://questionsmedicales.fr/author/Lei%20Si",
"affiliation": {
"@type": "Organization",
"name": "The George Institute for Global Health, UNSW Sydney, Kensington, Australia."
}
},
{
"@type": "Person",
"name": "Andrew J Palmer",
"url": "https://questionsmedicales.fr/author/Andrew%20J%20Palmer",
"affiliation": {
"@type": "Organization",
"name": "Menzies Institute for Medical Research, University of Tasmania, Menzies Institute for Medical Research, Hobart, Tasmania, Australia."
}
},
{
"@type": "Person",
"name": "Ziping Ye",
"url": "https://questionsmedicales.fr/author/Ziping%20Ye",
"affiliation": {
"@type": "Organization",
"name": "College of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, China."
}
},
{
"@type": "Person",
"name": "Lihua Sun",
"url": "https://questionsmedicales.fr/author/Lihua%20Sun",
"affiliation": {
"@type": "Organization",
"name": "College of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, China. sunlh@syphu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of the national hepatitis B immunization program in China: a modeling study.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36221140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40249-022-01032-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.",
"datePublished": "2024-06-10",
"url": "https://questionsmedicales.fr/article/38857859",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2357439"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.",
"datePublished": "2022-12-08",
"url": "https://questionsmedicales.fr/article/36503856",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.vaccine.2022.11.074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigation of non-National Immunization Program vaccination intentions in rural areas of China.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37542236",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16390-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.",
"datePublished": "2023-10-31",
"url": "https://questionsmedicales.fr/article/37956381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.17886"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Collecte de données",
"item": "https://questionsmedicales.fr/mesh/D003625"
},
{
"@type": "ListItem",
"position": 6,
"name": "Registre civil",
"item": "https://questionsmedicales.fr/mesh/D014798"
},
{
"@type": "ListItem",
"position": 7,
"name": "Espérance de vie",
"item": "https://questionsmedicales.fr/mesh/D008017"
},
{
"@type": "ListItem",
"position": 8,
"name": "Années de vie ajustées sur la qualité",
"item": "https://questionsmedicales.fr/mesh/D019057"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Années de vie ajustées sur la qualité - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Années de vie ajustées sur la qualité",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Années de vie ajustées sur la qualité",
"description": "Comment évaluer les QALY d'un patient ?\nQuels outils mesurent la qualité de vie ?\nLes QALY sont-ils utilisés en oncologie ?\nQuel rôle joue l'analyse coût-efficacité ?\nLes QALY sont-ils universels ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Années de vie ajustées sur la qualité",
"description": "Quels symptômes affectent la qualité de vie ?\nComment la dépression influence les QALY ?\nLes symptômes physiques affectent-ils les QALY ?\nQuels symptômes sont évalués dans les QALY ?\nLes symptômes mentaux impactent-ils les QALY ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Années de vie ajustées sur la qualité",
"description": "Comment la prévention affecte-t-elle les QALY ?\nLes vaccinations augmentent-elles les QALY ?\nQuel rôle joue l'éducation à la santé ?\nLes dépistages précoces influencent-ils les QALY ?\nComment le mode de vie impacte-t-il les QALY ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Années de vie ajustées sur la qualité",
"description": "Comment les traitements influencent-ils les QALY ?\nLes interventions chirurgicales augmentent-elles les QALY ?\nLes médicaments améliorent-ils les QALY ?\nQuel est l'impact des soins palliatifs sur les QALY ?\nLes traitements préventifs influencent-ils les QALY ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Années de vie ajustées sur la qualité",
"description": "Quelles complications réduisent les QALY ?\nLes complications mentales affectent-elles les QALY ?\nComment les complications cardiovasculaires influencent-elles les QALY ?\nLes complications liées au diabète impactent-elles les QALY ?\nLes complications respiratoires influencent-elles les QALY ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Années de vie ajustées sur la qualité",
"description": "Quels facteurs de risque diminuent les QALY ?\nL'âge est-il un facteur de risque pour les QALY ?\nLe stress impacte-t-il les QALY ?\nLes habitudes alimentaires influencent-elles les QALY ?\nL'alcool affecte-t-il les QALY ?",
"url": "https://questionsmedicales.fr/mesh/D019057?mesh_terms=Immunization+Programs&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les QALY d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les QALY sont calculés en multipliant les années de vie par un coefficient de qualité."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent la qualité de vie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires comme le EQ-5D ou le SF-36 sont utilisés pour mesurer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les QALY sont-ils utilisés en oncologie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les QALY aident à évaluer l'efficacité des traitements en oncologie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'analyse coût-efficacité ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle compare le coût des interventions par rapport aux QALY gagnés pour guider les décisions."
}
},
{
"@type": "Question",
"name": "Les QALY sont-ils universels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les valeurs de qualité de vie peuvent varier selon les cultures et les contextes."
}
},
{
"@type": "Question",
"name": "Quels symptômes affectent la qualité de vie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur chronique, la fatigue et l'anxiété impactent significativement la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment la dépression influence les QALY ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dépression réduit la qualité de vie, diminuant ainsi les QALY d'un individu."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques affectent-ils les QALY ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes physiques non traités peuvent réduire les QALY en altérant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont évalués dans les QALY ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes tels que la douleur, la mobilité et l'humeur sont souvent évalués."
}
},
{
"@type": "Question",
"name": "Les symptômes mentaux impactent-ils les QALY ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles mentaux peuvent significativement diminuer les QALY en affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment la prévention affecte-t-elle les QALY ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention réduit l'incidence des maladies, augmentant ainsi les QALY dans la population."
}
},
{
"@type": "Question",
"name": "Les vaccinations augmentent-elles les QALY ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations préviennent des maladies graves, augmentant les QALY."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation à la santé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation à la santé améliore les comportements de santé, augmentant les QALY."
}
},
{
"@type": "Question",
"name": "Les dépistages précoces influencent-ils les QALY ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet de traiter les maladies à un stade précoce, augmentant les QALY."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie impacte-t-il les QALY ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain (alimentation, exercice) améliore la qualité de vie et augmente les QALY."
}
},
{
"@type": "Question",
"name": "Comment les traitements influencent-ils les QALY ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements efficaces augmentent les QALY en améliorant la qualité et la durée de vie."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales augmentent-elles les QALY ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interventions chirurgicales peuvent améliorer la qualité de vie et augmenter les QALY."
}
},
{
"@type": "Question",
"name": "Les médicaments améliorent-ils les QALY ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments peuvent améliorer les QALY en soulageant les symptômes et en prolongeant la vie."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des soins palliatifs sur les QALY ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins palliatifs visent à améliorer la qualité de vie, augmentant ainsi les QALY."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs influencent-ils les QALY ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements préventifs peuvent augmenter les QALY en réduisant l'incidence des maladies."
}
},
{
"@type": "Question",
"name": "Quelles complications réduisent les QALY ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme les infections ou les comorbidités peuvent réduire les QALY."
}
},
{
"@type": "Question",
"name": "Les complications mentales affectent-elles les QALY ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications mentales comme l'anxiété peuvent diminuer les QALY en altérant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment les complications cardiovasculaires influencent-elles les QALY ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications cardiovasculaires peuvent réduire la durée et la qualité de vie, diminuant les QALY."
}
},
{
"@type": "Question",
"name": "Les complications liées au diabète impactent-elles les QALY ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications du diabète peuvent gravement affecter la qualité de vie et réduire les QALY."
}
},
{
"@type": "Question",
"name": "Les complications respiratoires influencent-elles les QALY ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications respiratoires peuvent réduire la qualité de vie et diminuer les QALY."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque diminuent les QALY ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le tabagisme, l'obésité et l'inactivité physique diminuent les QALY."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les QALY ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé est souvent associé à une diminution des QALY en raison de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le stress impacte-t-il les QALY ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la qualité de vie et réduire les QALY."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les QALY ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise alimentation peut augmenter le risque de maladies, diminuant les QALY."
}
},
{
"@type": "Question",
"name": "L'alcool affecte-t-il les QALY ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consommation excessive d'alcool peut réduire la qualité de vie et les QALY."
}
}
]
}
]
}
Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries...
We constructed an expanded Susceptible-Exposed-Infectious-Recovered (SEIR) model and decision tree-Markov model to estimate the epidemic of HBV in China, assess the feasibility of 2030 Elimination Goa...
Between 1990 and 2020, the number of chronic HBV infections decreased by 33.9%. The current status quo would lead to 55.73 million infections (3.95% prevalence) in 2030, compared to 90.63 million (6.4...
Our findings proved the HBV vaccination has demonstrated a substantial positive impact on controlling the epidemic of HBV in terms of effectiveness and economy after about 30 years of implementation o...
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...
Globally, rotavirus is a leading cause of severe acute gastroenteritis among children aged under 5 years and has a significant economic cost. Currently, rotavirus vaccines are only included in the pri...
A decision tree Markov model was constructed to evaluate the cost-benefit of universal immunization with three doses of rotavirus vaccine for a 2019 birth cohort of Chinese children. Costs of the univ...
For the 2019 birth cohort of Chinese infants, inclusion of RotaTeq in NIP was estimated to prevent 5,677,911 cases of rotavirus infection, with net savings of $1.1 billion in total societal costs. A c...
Introducing rotavirus vaccine into the China NIP would have significant costs from a societal perspective at the current private market price....
China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee...
A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac...
This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ...
Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...
Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a...
The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi...
While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect...
The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...
Despite widespread adoption of decentralization reforms, the impact of decentralization on health system attributes, such as access to health services, responsiveness to population health needs, and e...
This article analyzes the films produced and broadcast between 1976 and 1978 by the National Agency and the Public Relations Office (ARP) for the campaign to publicize the mandatory vaccination that w...
The introduction of Expanded Program on Immunization (EPI) and the availability of vaccines have contributed to significant reduction in morbidity and mortality rate, particularly among infants and ch...
The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization se...
We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine...
Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These...
WHO-recommended vaccines substantially prevent and control vaccine-preventable diseases (VPDs), but their inclusion differs among countries and regions. We reviewed the application for WHO-recommended...